Abstract |
Thyroid cancer (TC) is the most common endocrine malignancy without reliable preventive agent. Resveratrol possesses in vitro anti-TC activities; while its effect(s) on thyroid tumorigenesis remains unknown. This study aims to address this issue using DEN/MNU/ DHPN-induced rat carcinogenesis model. 50 male Sprague-Dawley rats were separated into four groups as Group-1 (5 rats); normally fed; Group-2 (15 rats); DEN/MNU/ DHPN treatment only; Group-3 (15 rats) and -4 (15 rats); DEN/MNU/ DHPN treatment; followed by resveratrol intragastric (IG) injection and intraperitoneal (IP) injection; respectively; in two-day intervals for 30 weeks. The results revealed that the average resveratrol concentration in thyroid tissues was 1.278 ± 0.419 nmol/g in IG group and 1.752 ± 0.398 nmol/g in IP group. The final body weights of Group-3 and Group-4 were lighter than that (p > 0.05) of Group-1; but heavier than Group-2 (p < 0.05). TC-related lesions ( hyperplasia and adenomas) were found in 53.3% of Group-2; 33.3% Group-3 and 26.7% Group-4. Lower serum carcino-embryonic antigen (CEA) and thyroglobulin (Tg) levels; down-regulated expression of IL-6 and cyclooxygenase-2 (COX-2); reduction of NF-κB/p65 nuclear translocation; and elevated IkBα expression were found in the thyroid tissues of Group-3 and Group-4 in comparison with that of Group-2. These results demonstrate that IG and IP administered resveratrol efficiently reduces the frequency and severity of DEN/MNU/ DHPN-caused TC-related lesions and would be of values in thyroid tumor prevention.
|
Authors | Xu Zheng, Bin Jia, Xue Song, Qing-You Kong, Mo-Li Wu, Ze-Wen Qiu, Hong Li, Jia Liu |
Journal | Nutrients
(Nutrients)
Vol. 10
Issue 3
(Feb 28 2018)
ISSN: 2072-6643 [Electronic] Switzerland |
PMID | 29495605
(Publication Type: Journal Article)
|
Chemical References |
- Anticarcinogenic Agents
- Carcinoembryonic Antigen
- Interleukin-6
- Nfkbia protein, rat
- Nitrosamines
- Rela protein, rat
- Stilbenes
- Transcription Factor RelA
- NF-KappaB Inhibitor alpha
- Diethylnitrosamine
- diisopropanolnitrosamine
- Methylnitrosourea
- Thyroglobulin
- Cyclooxygenase 2
- Ptgs2 protein, rat
- Resveratrol
|
Topics |
- Adenoma
(blood, chemically induced, pathology, prevention & control)
- Animals
- Anticarcinogenic Agents
(pharmacology)
- Carcinoembryonic Antigen
(blood)
- Cell Line, Tumor
- Cell Transformation, Neoplastic
(chemically induced, drug effects, metabolism, pathology)
- Cyclooxygenase 2
(metabolism)
- Diethylnitrosamine
- Humans
- Hyperplasia
- Interleukin-6
(metabolism)
- Male
- Methylnitrosourea
- NF-KappaB Inhibitor alpha
(metabolism)
- Nitrosamines
- Rats, Sprague-Dawley
- Resveratrol
- Stilbenes
(pharmacology)
- Thyroglobulin
(blood)
- Thyroid Gland
(drug effects, metabolism, pathology)
- Thyroid Neoplasms
(blood, chemically induced, pathology, prevention & control)
- Time Factors
- Transcription Factor RelA
(metabolism)
|